We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
Guidance posture was consistent, with Q1 reiterating "our $0.55 full year midpoint" and describing a narrowed full-year range; Q4 introduced the initial $0.51 to $0.59 range around that midpoint ...
Hosted on MSN
Blue Owl Capital outlines $1.4B asset sale at book value while advancing share repurchases and portfolio resilience
Earnings Call Insights: Blue Owl Capital Corporation (OBDC) Q4 2025 Craig Packer, CEO, began by addressing recent investor scrutiny over credit quality in private credit, stating, "credit quality in ...
When companies talk about mergers and acquisitions, the conversation usually revolves around tax treatment, valuation, and deal structure. What often gets overlooked—until it’s too late—is the 401(k) ...
Editor’s note: This article has been updated to include the company’s latest statement and a revised headline. A $1.4 billion asset sale, redemptions halted and software stocks' downfall by trillions.
According to the Local Democracy Reporting Service, properties listed by the authority as sold subject to contract include ...
Ryan M. Lance, CEO, announced "another strong execution quarter, once again exceeding the top end of our production guidance range," and confirmed the midpoint of full year production guidance remains ...
ORLANDO, Fla.--(BUSINESS WIRE)--Luminar Technologies, Inc. (OTC: LAZRQ) (the “Company” or “Luminar”), today announced that it is commencing a tender offer (the “Asset Sale Offer”) to purchase for cash ...
Investors, business owners and real estate holders today face a critical dilemma when exiting highly appreciated assets: how to manage capital gains tax, retain income and preserve generational wealth ...
Abeona Therapeutics is a commercial-stage biotech focused on developing cell and gene therapies for severe and rare diseases. Its portfolio centers around ZEVASKYN, an autologous cell-based gene ...
The owner is retiring with pride, knowing the business was built on quality, precision, and reliability. This sale allows the next generation to benefit from decades of investment and craftsmanship.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results